Evidence map›Paper›PMID 29921039›Full record

ArticleJournal of cellular and molecular medicine2018

Identification of new biophysical markers for pathological ventricular remodelling in tachycardia-induced dilated cardiomyopathy.

Aleyda Benitez-Amaro, Valerie Samouillan, Esther Jorge, Jany Dandurand, Laura Nasarre, David de Gonzalo-Calvo, Olga Bornachea, Gerard Amoros-Figueras, Colette Lacabanne, David Vilades and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Changes of two-pore K+ channel TASK-1 in diabetic myocardial injury in rats].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Aleyda Benitez-AmaroGroup of Lipids and Cardiovascular Pathology, ICCC Program, Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Valerie SamouillanCIRIMAT, Université de Toulouse, Université Paul Sabatier, Physique des Polymères, Toulouse, France.
Esther JorgeCIBERCV, Barcelona, Spain.
Jany DandurandCIRIMAT, Université de Toulouse, Université Paul Sabatier, Physique des Polymères, Toulouse, France.
Laura NasarreGroup of Lipids and Cardiovascular Pathology, ICCC Program, Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
David de Gonzalo-CalvoGroup of Lipids and Cardiovascular Pathology, ICCC Program, Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Olga BornacheaGroup of Lipids and Cardiovascular Pathology, ICCC Program, Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Gerard Amoros-FiguerasCIBERCV, Barcelona, Spain.
Colette LacabanneCIRIMAT, Université de Toulouse, Université Paul Sabatier, Physique des Polymères, Toulouse, France.
David ViladesDepartment of Cardiology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autonoma de Barcelona, Barcelona, Spain.
Ruben LetaDepartment of Cardiology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autonoma de Barcelona, Barcelona, Spain.
Francesc CarrerasCIBERCV, Barcelona, Spain.
Alberto GallardoDepartment of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Enrique LermaDepartment of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Juan CincaCIBERCV, Barcelona, Spain.
Jose M GuerraCIBERCV, Barcelona, Spain.
Vicenta Llorente-CortésGroup of Lipids and Cardiovascular Pathology, ICCC Program, Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID 0000-0001-8591-7632
Universitat Autònoma de Barcelona · ESConsejo Superior de Investigaciones Científicas · ESHospital de Sant Pau · ESUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our aim was to identify biophysical biomarkers of ventricular remodelling in tachycardia-induced dilated cardiomyopathy (DCM). Our study includes healthy controls (N = 7) and DCM pigs (N = 10). Molecular analysis showed global myocardial metabolic abnormalities, some of them related to myocardial hibernation in failing hearts, supporting the translationality of our model to study cardiac remodelling in dilated cardiomyopathy. Histological analysis showed unorganized and agglomerated collagen accumulation in the dilated ventricles and a higher percentage of fibrosis in the right (RV) than in the left (LV) ventricle (P = .016). The Fourier Transform Infrared Spectroscopy (FTIR) 1st and 2nd indicators, which are markers of the myofiber/collagen ratio, were reduced in dilated hearts, with the 1st indicator reduced by 45% and 53% in the RV and LV, respectively, and the 2nd indicator reduced by 25% in the RV. The 3rd FTIR indicator, a marker of the carbohydrate/lipid ratio, was up-regulated in the right and left dilated ventricles but to a greater extent in the RV (2.60-fold vs 1.61-fold, P = .049). Differential scanning calorimetry (DSC) showed a depression of the freezable water melting point in DCM ventricles - indicating structural changes in the tissue architecture - and lower protein stability. Our results suggest that the 1st, 2nd and 3rd FTIR indicators are useful markers of cardiac remodelling. Moreover, the 2nd and 3rd FITR indicators, which are altered to a greater extent in the right ventricle, are associated with greater fibrosis.

Indexed as

Ventricular RemodelingAnimalsBiomarkersCalorimetry, Differential ScanningCarbohydratesCardiomyopathy, DilatedCase-Control StudiesCollagenFemaleHeart VentriclesHumansLipidsMyocardial StunningMyocardiumMyofibrilsSpectroscopy, Fourier Transform InfraredBiomarkersCarbohydratesCollagenLipidsbiophysical markerscardiac remodellingcollagendifferential scanning calorimetryfourier transform infrared spectroscopyheart failuremyofiber

Identifiers

PMID29921039
PMCPMC6111813
OpenAlexW2809211076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.